Kevin L. Duffin
0000-0002-1656-8982
Publication & Citation Trends
Publications
0 total
Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseases OA
Cited by 9
Semantic Scholar
Cross-Species Molecular Mapping Reveals Early Innate Immune Activation Driving CKD Progression in Mice
Cited by 0
Semantic Scholar
The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
Cited by 0
Semantic Scholar
Profiles of Circulating MicroRNAs Associated with the Development of ESKD in Diabetes
Cited by 0
Semantic Scholar
Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes
Cited by 14
Semantic Scholar
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine OA
Cited by 22
Semantic Scholar
Mature MicroRNA (miRNA)-1287-5p and miRNA-197-5p Are Upregulated in Diabetic Kidney Disease
Cited by 0
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(26)
Chronic Kidney Disease and Diabetes
(26)
Spectroscopy and Laser Applications
(26)
Liver Disease Diagnosis and Treatment
(22)
Metabolism, Diabetes, and Cancer
(16)
Affiliations
Monsanto (United States)
Dalhousie University
University Health Network
University Medical Center Groningen
Eli Lilly (United States)